BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19747804)

  • 1. Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection.
    Franciosi M; Maione A; Pomili B; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E; Nicolucci A
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):7-14. PubMed ID: 19747804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
    ; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
    Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus--a large-scale multicentre pilot study.
    Müller-Godeffroy E; Treichel S; Wagner VM;
    Diabet Med; 2009 May; 26(5):493-501. PubMed ID: 19646189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of continuous subcutaneous insulin infusion on health-related quality of life in children and adolescents with type 1 diabetes.
    Júlíusson PB; Graue M; Wentzel-Larsen T; Søvik O
    Acta Paediatr; 2006 Nov; 95(11):1481-7. PubMed ID: 17062481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and diabetes knowledge of young persons with type 1 diabetes: Influence of treatment modalities and demographics.
    O'Neil KJ; Jonnalagadda SS; Hopkins BL; Kicklighter JR
    J Am Diet Assoc; 2005 Jan; 105(1):85-91. PubMed ID: 15635351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
    Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
    Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Satisfaction and quality of life evaluation in patients with type 1 diabetes mellitus treated using continuous subcutaneous insulin infusion compared with multiple daily injections].
    Lozano-Serrano M; García-Seco JA; García-Seco F; Lozano-Hernández MC; Seco-Segura ÁM; Moreno-Fernández J; Muñoz-Cazallas PA; Ferreiro-Vicario C; Sánchez-Covisa MA
    Enferm Clin; 2013; 23(3):96-102. PubMed ID: 23755944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes-specific variables associated with quality of life changes in young diabetic people: the type 1 diabetes Registry of Turin (Italy).
    Trento M; Panero F; Porta M; Gruden G; Barutta F; Cerutti F; Gambino R; Perotto M; Cavallo Perin P; Bruno G;
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):1031-6. PubMed ID: 23466181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type 1) diabetic children: evaluation after two years of therapy.
    Slijper FM; De Beaufort CE; Bruining GJ; De Visser JJ; Aarsen RS; Kicken DA; Van Strik R
    Diabete Metab; 1990; 16(4):273-7. PubMed ID: 2265733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and associations of psychological distress in young adults with Type 1 diabetes.
    Hislop AL; Fegan PG; Schlaeppi MJ; Duck M; Yeap BB
    Diabet Med; 2008 Jan; 25(1):91-6. PubMed ID: 18199136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
    Radermecker RP; Scheen AJ
    Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality of life with intensive insulin therapy: a prospective comparison of insulin pen and pump].
    Schiffers T
    Psychother Psychosom Med Psychol; 1997 Jul; 47(7):249-54. PubMed ID: 9333836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of factors affecting quality of life in diabetic patients in Iran.
    Ghanbari A; Yekta ZP; Roushan ZA; Lakeh NM
    Public Health Nurs; 2005; 22(4):311-22. PubMed ID: 16150012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
    Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M
    Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.